THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO;CONSEJO SUPERIOR DE INVESTIGACIONES CIENIFICAS (CSIC)
发明人:
申请号：
IL25542017
公开号：
IL255420D0
申请日:
2017.11.05
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
The present invention relates to a family of chromenopyrazole derivatives of formula (I): which have the ability to modulate the receptor of the cannabinoid family GPR55, whereby the invention also relates to the use of these compounds for the manufacture of a medicament for the treatment of diseases in which the GPR55 receptor has a physiological role such as diabetes, Parkinson's disease, multiple sclerosis, neuropathic pain, osteoporosis and cancers such as cholangiocarcinoma, breast cancer, ovarian and prostate cancer, glioblastoma, and cutaneous carcinoma.
